

[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI
[ Mon, Aug 21st 2023
] - WOPRAI

[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
[ Fri, Aug 18th 2023
] - WOPRAI
Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $11 on, Aug 18th, 2023
Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $60 to $11 on, Aug 18th, 2023.
Raghuram has made no other calls on BTAI in the last 4 months.
There are 5 other peers that have a rating on BTAI. Out of the 5 peers that are also analyzing BTAI, 3 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Decreased Target to $4 on, Tuesday, August 15th, 2023
- Graig Suvannavejh of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $4 on, Tuesday, August 15th, 2023
- Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, July 17th, 2023
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $31 on, Tuesday, August 15th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, August 15th, 2023
Contributing Sources